Mar 18, 2024 6:15am EDT Ross Acquisition Corp II Announces Suspension and Expected De-Listing from the New York Stock Exchange and Intention to Seek Listing on the Nasdaq Stock Market
Feb 29, 2024 4:20pm EST Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
Sep 15, 2023 2:45pm EDT Ross Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business Combination
Sep 01, 2023 6:00am EDT Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
Aug 28, 2023 4:31pm EDT Ross Acquisition Corp II Receives NYSE Notice Regarding Delayed Form 10-Q Filing
Jan 18, 2023 6:50am EST APRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative Diseases
May 27, 2021 6:48pm EDT Ross Acquisition Corp II Receives Expected NYSE Notice Regarding Delayed Form 10-Q Filing
May 03, 2021 2:45pm EDT Ross Acquisition Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing May 3, 2021
Mar 11, 2021 6:48pm EST Ross Acquisition Corp II Announces Pricing of $300 Million Initial Public Offering
